IL2RA and neoplasm: Increased sVCAM‐1, reflecting endothelial dysfunction, elevated soluble IL‐2R (sIL‐2R), indicating a proinflammatory state, and high tumor burden before lymphodepletion were key risk factors for CAR‐T‐associated hematotoxicity.